Ophthalmology

Research and innovation from Vanderbilt Eye Institute experts

Latest in Ophthalmology

African-American man taking an eye exam at a clinic.

Gene Variations Linked to Glaucoma Risk

Risk variants of primary open-angle glaucoma may be ancestry-specific, sex-specific, or both.
Eye surgery simulation

New Leadership Brings Fresh Insights to Vision Care

Vanderbilt’s new chair of ophthalmology and visual sciences looks forward to the future of the Vanderbilt Eye Institute.
Close up of eye being examined

Predictors of Diabetic Retinopathy Under Scrutiny

Identifying specific inflammation mediators will help retina specialists anticipate and treat factors in retinopathy disease progression.

Medical expertise infused with integrated technology allows Vanderbilt Health specialists to build partnerships and elevate care in complex and specialized cases. Browse our referral directory or log into our online portal for referring providers.

Make a Referral

Expanding VEI Program Helps Patients Thrive

Through comprehensive care and ongoing support, our low vision clinic helps children and adults with vision loss better navigate their environment.
Beagle eye

Beagle Genomics Spark Advances in Human Glaucoma

Gene variant discovered to cause RGC degeneration in beagles with inherited disease also has causative effects in a mouse model.
A doctor putting eye drops in a girl's eye

Atropine Response Varies for Pediatric Myopia

NEI-funded trial finds low-dose eye drops may not be effective at slowing the progression of nearsightedness in some children.
Patient undergoing telehealth consult

Telehealth Overcomes Distance for Specialty Consultations

Neurology forges a wider path for specialty consulting services using technology.
Eye closeup

Scleral Lenses a Good Fit for Complex Eye Diseases

With advances in fitting technology, scleral contact lenses are now being used for an increasingly wide range of therapeutic applications.
Man using magnifying glass

Promising Strategies for Treating Macular Degeneration

Durable injections, gene therapy, and a novel treatment for dry AMD aim to slow disease progression and decrease treatment burden.